A Prospective Study of the Efficacy and Safety of Additional Pulsed Field Ablation for Atrial Fibrillation

A Prospective Study of the Efficacy and Safety of Additional Pulsed Field Ablation for Atrial Fibrillation - A Prospective Study of the Efficacy and Safety of Additional Pulsed Field Ablation for Atrial Fibrillation

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000057298

Enrollment

100

Registered

2025-05-01

Start date

2025-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial fibrillation

Interventions

During atrial fibrillation ablation, additional application with pulsed-field ablation is performed if atrial tachycardia/flutter, non-pulmonary venous origin, or arrhythmia substrate is suspected in

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All of the following must be met 1) Patients undergoing ablation for atrial fibrillation (of any duration). 2) Female/male patients who are at least 18 years old and less than 90 years old at the time of consent/enrollment.

Exclusion criteria

Exclusion criteria: Patients should be excluded if any of the following apply 1) Patients with contraindications to anticoagulation. 2) Patients with evidence of thrombus in the left atrium. 3) Other patients who are judged by the principal investigator or co-investigators to be inappropriate for this study.

Design outcomes

Primary

Measure	Time frame
Acute phase effects of additional applications with pulsed field ablation (isolation and block line success rate, with or without dormant conduction with ATP administration)	—

Countries

Japan

Contacts

Public ContactShushi Nishiwaki

Kyoto University Hospital Department of Clinical Laboratory

s_nishiwaki@kuhp.kyoto-u.ac.jp0757514255

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026